Suppr超能文献

肿瘤浸润调节性 T 细胞通过 PD-1 和抑制性受体的上调来界定。

Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors.

机构信息

Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.

出版信息

Cell Immunol. 2012 Jul-Aug;278(1-2):76-83. doi: 10.1016/j.cellimm.2012.07.001. Epub 2012 Jul 24.

Abstract

Foxp3(+) regulatory T (T(reg)) cells are dominant suppressor cells which regulate conventional T (T(conv)) cells. Inside tumor microenvironment, T(reg) cells have been known to become potent in suppressing T(conv) cell responses, thereby enabling tumor cells to circumvent immune response. However, the underlying mechanism by which tumor-infiltrating T(reg) cells display enhanced suppressive function is still unresolved. To understand characteristics and function of tumor-infiltrating T(reg) cells as well as T(conv) cells in the tumor site, we analyzed their phenotypes either within tumor burden or at distant site of tumor using both heterotopic and orthotopic mouse cancer models. Compared to CD8(+) T cells at distant site of tumor, tumor-infiltrating CD8(+) T cells dramatically upregulated programmed death 1 (PD-1) and other inhibitory receptors, thereby being more exhausted functionally. Tumor-infiltrating CD4(+) T cells also expressed higher level of PD-1 than CD4(+) T cells at distant site of tumor but very surprisingly, upregulation of PD-1 occurred in CD4(+)Foxp3(+) T(reg) as well as CD4(+)Foxp3(-) T(conv) cells. Moreover, tumor infiltrating T(reg) cells upregulated other inhibitory receptors such as T cell immunoglobulin mucin 3 (TIM-3), cytotoxic T lymphocyte antigen-4 (CTLA-4), glucocorticoid-induced tumor necrosis factor receptor (GITR), and lymphocyte activation gene-3 (LAG-3). These results suggest that upregulation of PD-1 and other inhibitory receptors on tumor-infiltrating T(reg) cells is related with their enhanced suppressive function.

摘要

Foxp3(+) 调节性 T(T(reg))细胞是调节常规 T(T(conv))细胞的主要抑制性细胞。在肿瘤微环境中,T(reg)细胞已被证实能够有效地抑制 T(conv)细胞的反应,从而使肿瘤细胞能够逃避免疫反应。然而,肿瘤浸润 T(reg)细胞显示增强的抑制功能的潜在机制仍未解决。为了了解肿瘤部位浸润的 T(reg)细胞和 T(conv)细胞的特征和功能,我们使用异位和原位小鼠癌症模型分析了它们在肿瘤负荷内或远离肿瘤部位的表型。与远离肿瘤部位的 CD8(+) T 细胞相比,肿瘤浸润的 CD8(+) T 细胞显著上调程序性死亡受体 1(PD-1)和其他抑制性受体,从而在功能上更加衰竭。肿瘤浸润的 CD4(+) T 细胞也表达高于远离肿瘤部位的 CD4(+) T 细胞的 PD-1,但非常令人惊讶的是,PD-1 的上调发生在 CD4(+)Foxp3(+) T(reg)以及 CD4(+)Foxp3(-) T(conv)细胞中。此外,肿瘤浸润的 T(reg)细胞还上调了其他抑制性受体,如 T 细胞免疫球蛋白粘蛋白 3(TIM-3)、细胞毒性 T 淋巴细胞抗原-4(CTLA-4)、糖皮质激素诱导的肿瘤坏死因子受体(GITR)和淋巴细胞激活基因-3(LAG-3)。这些结果表明,PD-1 和其他抑制性受体在肿瘤浸润 T(reg)细胞上的上调与其增强的抑制功能有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验